New Trends in Qualitative Research,
Journal Year:
2024,
Volume and Issue:
20(3), P. e1053 - e1053
Published: Aug. 26, 2024
Introducción:
Este
estudio
examina
la
revolución
tecnológica
en
el
ámbito
de
los
dispositivos
médicos
conectados,
que
están
redefiniendo
monitoreo,
diagnóstico
y
tratamiento
enfermedades.
Se
analiza
cómo
integración
tecnologías
avanzadas
está
impulsando
atención
médica
personalizada
a
distancia.
Objetivos:
Evaluar
avances
conectados
su
impacto
mejora
del
monitoreo
investiga
estas
cambiando
dinámica
cuáles
son
desafíos
oportunidades
asociados.
Metodología:
utiliza
un
enfoque
cualitativo,
vinculando
preguntas
investigación
con
teorías
resultados.
El
se
basa
análisis
wearables
sistemas
implantables,
combinando
revisión
literatura
entrevistas
expertos
datos.
metodológico
permite
una
comprensión
profunda
interacción
entre
tecnología
práctica
médica.
Resultados:
Los
hallazgos
muestran
ofrecen
significativas
ventajas
términos
precisión
eficiencia,
permitiendo
seguimiento
tiempo
real
mejor
toma
decisiones
clínicas.
identifican
retos
técnicos,
éticos
regulatorios,
pero
también
destacan
soluciones
innovadoras
para
superarlos.
Conclusiones:
La
subraya
importancia
cualitativo
conectados.
resultados
enfatizan
necesidad
marco
robusto
evaluar
tanto
tecnológicos
como
contribuye
transformando
médica,
enfatizando
abordajes
integrados
multidisciplinarios
maximizar
sus
beneficios
minimizar
riesgos.
Biosensors,
Journal Year:
2025,
Volume and Issue:
15(2), P. 88 - 88
Published: Feb. 5, 2025
Surface
acoustic
wave
(SAW)
sensor
technology
is
a
promising
approach
to
diagnosing
cancer
through
the
detection
of
biomarkers
due
its
high
sensitivity,
potential
label-free
operation,
and
fast
response
times,
and,
fundamentally,
because
it
non-invasive
technique
in
comparison
with
current
traditional
diagnostic
techniques
for
cancer.
This
review
focuses
on
this
application,
purpose,
recent
literature
detected
by
advanced
has
been
compiled,
including
that
volatile
organic
compounds
(VOCs)
from
exhaled
breath
larger
biomolecules
such
as
proteins,
DNA,
microRNAs
body
fluids,
which
demonstrates
great
versatility.
The
conventional
biomarker
biofluids,
ELISA,
PCR,
SPR,
UV
absorbance,
exhibit
limitations
costs,
slow
reduced
need
specialized
instrumentation,
requirement
highly
trained
personnel.
Different
SAW
configurations
are
discussed
attention
paid
their
specific
properties,
propagation
modes,
suitability
different
environments.
Detailed
studies
reviewed,
highlighting
lung,
colorectal,
prostate,
breast,
ovarian
diagnostics,
well
circulating
tumor
cells
cancerous
cell
growth.
identifies
challenges,
optimizing
addressing
environmental
interferences,
clinical
validation.
Finally,
future
research
directions
proposed,
emphasizing
use
VOC
integration
into
hybrid
systems
microfluidic
platforms
enable
creation
scalable,
tools
early
stages,
way,
minimize
morbidity
mortality
associated
disease.
Microchimica Acta,
Journal Year:
2025,
Volume and Issue:
192(5)
Published: April 9, 2025
Abstract
The
isolation
of
a
single
atomic
layer
graphite,
known
as
graphene,
marked
fundamental
moment
that
transformed
the
field
materials
science.
Graphene-based
nanomaterials
are
recognized
for
their
superior
biocompatibility
compared
with
many
other
types
nanomaterials.
Moreover,
one
main
reasons
growing
interest
in
graphene
is
its
potential
applications
emerging
technologies.
Its
key
characteristics,
including
high
electrical
conductivity,
excellent
intrinsic
charge
carrier
mobility,
optical
transparency,
substantial
specific
surface
area,
and
remarkable
mechanical
flexibility,
position
it
an
ideal
candidate
solar
cells
touch
screens.
durability
further
establishes
strong
contender
developing
robust
materials.
To
date,
variety
methods,
such
traditional
spectroscopic
techniques
chromatographic
approaches,
have
been
developed
detecting
biomolecules,
drugs,
heavy
metals.
Electrochemical
portability,
selectivity,
impressive
sensitivity,
offer
considerable
convenience
both
patients
professionals
point-of-care
diagnostics.
Recent
advancements
significantly
improved
capacity
rapid
accurate
detection
analytes
trace
amounts,
providing
benefits
biosensor
technology.
Additionally,
integration
nanotechnology
has
markedly
enhanced
sensitivity
selectivity
electrochemical
sensors,
yielding
results.
Innovations
point-of-care,
lab-on-a-chip,
implantable
devices,
wearable
sensors
discussed
this
review.
Graphical
abstract
Biosensors,
Journal Year:
2025,
Volume and Issue:
15(4), P. 257 - 257
Published: April 17, 2025
Innovative
biosensor
technologies
are
revolutionizing
cancer
detection
by
offering
non-invasive,
sensitive,
and
rapid
diagnostic
tools,
addressing
the
limitations
of
conventional
screening.
Non-invasive
samples
like
breath,
saliva,
urine,
sweat,
analyzed
using
advanced
electronic
nose
systems
AI,
show
promise
for
early
frequent
monitoring,
though
validation
is
needed.
AI
integration
enhances
data
analysis
personalization.
While
blood-based
methods
remain
gold
standard,
combining
them
with
less
invasive
sample
types
saliva
or
sensitive
techniques,
a
promising
direction.
Conventional
(mammography,
MRI,
etc.)
offer
proven
efficacy,
but
costly
invasive.
biosensors
reduced
infrastructure
needs,
lower
costs,
patient-friendly
sampling.
However,
challenges
in
validation,
standardization,
low
biomarker
concentrations.
Integrating
both
methodologies
could
create
comprehensive
framework,
reliability
accessibility.
Future
research
should
focus
on
robust
development,
expanding
application
to
other
cancers,
exploring
less-studied
improving
affordability
wider
adoption,
especially
resource-limited
settings.
The
future
lies
integrating
diverse
approaches
more
specific,
screening,
outcomes.
